Corbus Pharmaceuticals Holdings (CRBP) Receivables (2016 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Receivables of $2.5 million for Q3 2021, up 160.39% year-over-year from $960091.0 in Q3 2020, and little changed quarter-over-quarter from $2.5 million in Q2 2021.
Corbus Pharmaceuticals Holdings (CRBP) Receivables (2016 - 2021) Analysis & Trends
Corbus Pharmaceuticals Holdings' Receivables history runs 5 years deep, the most recent figure standing at $2.5 million for Q3 2021.
- In Q3 2021, Receivables rose 160.39% year-over-year to $2.5 million; the TTM figure through Sep 2021 stood at $2.5 million (up 160.39% YoY), while the FY2020 annual figure was $1.6 million, down 39.64% from the prior year.
- Receivables for Q3 2021 stood at $2.5 million, roughly flat from $2.5 million in the prior quarter.
- The five-year high for Receivables was $4.4 million in Q1 2020, with the low at $500000.0 in Q3 2017.
- The 4-year median for Receivables is $2.5 million (2021), against an average of $2.2 million.
- Peak annual rise in Receivables reached 160.39% in 2021, while the deepest fall reached 43.73% in 2021.
- Corbus Pharmaceuticals Holdings' Receivables stood at $500000.0 in 2017, then surged by 436.21% to $2.7 million in 2019, then sank by 39.64% to $1.6 million in 2020, then jumped by 54.48% to $2.5 million in 2021.
- Business Quant data shows CRBP's Receivables at $2.5 million in Q3 2021, $2.5 million in Q2 2021, and $2.5 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | Corbus Pharmaceuticals Holdings | 121.72 Mn | -41.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 2.50 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Mar 31, 2021 | 2.50 Mn |
| Dec 31, 2020 | 1.62 Mn |
| Sep 30, 2020 | 960,091.00 |
| Mar 31, 2020 | 4.44 Mn |
| Dec 31, 2019 | 2.68 Mn |
| Sep 30, 2017 | 500,000.00 |
| Dec 31, 2016 | 1.00 Mn |